drugset / Trial / NCT03380975

Role of Montelukast in Asthma and Allergic Rhinitis Patients

NCT03380975

Phase 4 Completed 600 enrolled Clinision
NaSingle-groupOpen-labelTreatment

Summary

To determine the effect of Montelukast in Asthma and Allergic rhinits patients

Timeline

Start
2018-08-28
Primary completion
2019-03-25
Completion
2019-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified 10 mg Oral